Cervical cancer develops over years through well-defined precancerous stages, making it one of the most preventable solid tumors in clinical practice. Yet more than a third of cervical cancer deaths occur in women over 65 — a population where screening is frequently discontinued too early and symptoms are attributed to other causes. The highest incidence is in women aged 65 to 69. When diagnosed, older women present at advanced stage 71% of the time, and their five-year survival is roughly half that of younger patients. Prevention works. The gap is in follow-through.
AAVBC's Cervical Cancer Quick Reference Guide gives primary care clinicians a practical reference for screening, recognition, and documentation across the full age spectrum. It covers HPV-associated disease classification, age-appropriate screening thresholds, colposcopy criteria, ICD-10 subsite coding, FIGO staging, metastatic site documentation, and MEAT documentation standards — grounded in current NCCN, ASCCP, and USPSTF guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of cervical cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
Cervical cancer develops over years through well-defined precancerous stages, making it one of the most preventable solid tumors in clinical practice. Yet more than a third of cervical cancer deaths occur in women over 65 — a population where screening is frequently discontinued too early and symptoms are attributed to other causes. The highest incidence is in women aged 65 to 69. When diagnosed, older women present at advanced stage 71% of the time, and their five-year survival is roughly half that of younger patients. Prevention works. The gap is in follow-through.
AAVBC's Cervical Cancer Quick Reference Guide gives primary care clinicians a practical reference for screening, recognition, and documentation across the full age spectrum. It covers HPV-associated disease classification, age-appropriate screening thresholds, colposcopy criteria, ICD-10 subsite coding, FIGO staging, metastatic site documentation, and MEAT documentation standards — grounded in current NCCN, ASCCP, and USPSTF guideline evidence.
AAVBC’s Deep-Dive series offers a comprehensive, structured analysis of cervical cancer — moving far beyond quick-reference essentials. These guides provide an integrated review of epidemiology, diagnostic strategy, staging, coding logic, MEAT-aligned documentation examples, treatment guidelines, review vulnerabilities, and cost-utilization considerations. The Deep-Dive combines evidence-informed clinical guidance with practical operational tools to support a deeper understanding of disease complexity and provide multidisciplinary teams with strategies to thrive within value-based frameworks.
